top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
HNT962
Head and neck disease tissue array, set 2, non-overlapping with HNT961, 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynx, larynx and salivary glands in duplicates with grading and TNM staging data
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Head and Neck
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evicence of primary tumor
Tis - Carcinoma in situ
T1 - Tumor invades lamina propria or submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades adventitia
T4 - Tumor invades adjacent structures
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
48
96
1.5 mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in various head and neck tumors.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 13 | Head and neck, salivary gland | Inflammation | |||
A02 | M | 63 | Larynx | Inflammation | |||
A03 | M | 41 | Head and neck, nasal cavity | Polyps | |||
A04 | F | 67 | Head and neck, nasal cavity | Polyps | |||
A05 | M | 60 | Head and Neck, left parotid gland | Hemangioma | |||
A06 | M | 40 | Head and neck, left lower mandible | Hemangioma | |||
A07 | M | 8 | Head and Neck, left neck | Neurofibroma | |||
A08 | M | 31 | Face | Neurofibroma | |||
A09 | M | 24 | Head and Neck, left neck | Schwannoma | |||
A10 | F | 30 | Head and Neck, left neck | Schwannoma | |||
A11 | F | 32 | Head and neck, salivary gland | Pleomorphic adenoma | |||
A12 | M | 52 | Head and Neck, left parotid gland | Pleomorphic adenoma | |||
B01 | M | 13 | Head and neck, salivary gland | Inflammation | |||
B02 | M | 63 | Larynx | Inflammation | |||
B03 | M | 41 | Head and neck, nasal cavity | Polyps | |||
B04 | F | 67 | Head and neck, nasal cavity | Polyps | |||
B05 | M | 60 | Head and Neck, left parotid gland | Hemangioma | |||
B06 | M | 40 | Head and neck, left lower mandible | Hemangioma | |||
B07 | M | 8 | Head and Neck, left neck | Neurofibroma | |||
B08 | M | 31 | Face | Neurofibroma | |||
B09 | M | 24 | Head and Neck, left neck | Schwannoma | |||
B10 | F | 30 | Head and Neck, left neck | Schwannoma | |||
B11 | F | 32 | Head and neck, salivary gland | Pleomorphic adenoma | |||
B12 | M | 52 | Head and Neck, left parotid gland | Pleomorphic adenoma | |||
C01 | M | 74 | Larynx | Squamous cell carcinoma | I | T3N0M0 | |
C02 | M | 58 | Larynx | Squamous cell carcinoma | I | T2N0M0 | |
C03 | M | 67 | Larynx | Squamous cell carcinoma | I | T2N1M0 | |
C04 | F | 46 | Head and neck, oral cavity | Squamous cell carcinoma | I | T2N2M0 | |
C05 | M | 63 | Larynx | Squamous cell carcinoma | I | T3N1M0 | |
C06 | M | 42 | Head and neck, oral cavity | Squamous cell carcinoma | I | T3N1M0 | |
C07 | M | 56 | Pharynx | Squamous cell carcinoma | I | T3N1M0 | |
C08 | M | 60 | Larynx | Squamous cell carcinoma | I~II | T2N1M0 | |
C09 | M | 57 | Pharynx | Squamous cell carcinoma | I~II | T2N0M0 | |
C10 | M | 54 | Larynx | Squamous cell carcinoma | I~II | T2N0M0 | |
C11 | M | 55 | Head and neck, oral cavity | Squamous cell carcinoma | I~II | T2N1M0 | |
C12 | M | 65 | Head and neck, oral cavity | Squamous cell carcinoma | I~II | T2N0M0 | |
D01 | M | 74 | Larynx | Squamous cell carcinoma | I | T3N0M0 | |
D02 | M | 58 | Larynx | Squamous cell carcinoma | I | T2N0M0 | |
D03 | M | 67 | Larynx | Squamous cell carcinoma | I | T2N1M0 | |
D04 | F | 46 | Head and neck, oral cavity | Squamous cell carcinoma | I | T2N2M0 | |
D05 | M | 63 | Larynx | Squamous cell carcinoma | I | T3N1M0 | |
D06 | M | 42 | Head and neck, oral cavity | Squamous cell carcinoma | I | T3N1M0 | |
D07 | M | 56 | Pharynx | Squamous cell carcinoma | I | T3N1M0 | |
D08 | M | 60 | Larynx | Squamous cell carcinoma | I~II | T2N1M0 | |
D09 | M | 57 | Pharynx | Squamous cell carcinoma | I~II | T2N0M0 | |
D10 | M | 54 | Larynx | Squamous cell carcinoma | I~II | T2N0M0 | |
D11 | M | 55 | Head and neck, oral cavity | Squamous cell carcinoma | I~II | T2N1M0 | |
D12 | M | 65 | Head and neck, oral cavity | Squamous cell carcinoma | I~II | T2N0M0 | |
E01 | M | 56 | Larynx | Squamous cell carcinoma | II | T2N0M0 | |
E02 | M | 65 | Larynx | Squamous cell carcinoma | II | T1N0M0 | |
E03 | F | 69 | Head and neck, salivary gland | Squamous cell carcinoma | II | T1N0M0 | |
E04 | M | 59 | Epiglottis | Squamous cell carcinoma | II~III | T2N0M0 | |
E05 | M | 55 | Larynx | Squamous cell carcinoma | II~III | T2N1M0 | |
E06 | M | 67 | Larynx | Squamous cell carcinoma | II~III | T3N1M0 | |
E07 | M | 47 | Pharynx | Squamous cell carcinoma | II~III | T2N1M0 | |
E08 | M | 44 | Larynx | Squamous cell carcinoma | II~III | T1N1M0 | |
E09 | M | 62 | Larynx | Squamous cell carcinoma | III | T1N1M0 | |
E10 | M | 64 | Head and neck, oral cavity | Squamous cell carcinoma | III | T2N2M0 | |
E11 | F | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
E12 | M | 64 | Pharynx | Squamous cell carcinoma | III | T2N0M0 | |
F01 | M | 56 | Larynx | Squamous cell carcinoma | II | T2N0M0 | |
F02 | M | 65 | Larynx | Squamous cell carcinoma | II | T1N0M0 | |
F03 | F | 69 | Head and neck, salivary gland | Squamous cell carcinoma | II | T1N0M0 | |
F04 | M | 59 | Epiglottis | Squamous cell carcinoma | II~III | T2N0M0 | |
F05 | M | 55 | Larynx | Squamous cell carcinoma | II~III | T2N1M0 | |
F06 | M | 67 | Larynx | Squamous cell carcinoma | II~III | T3N1M0 | |
F07 | M | 47 | Pharynx | Squamous cell carcinoma | II~III | T2N1M0 | |
F08 | M | 44 | Larynx | Squamous cell carcinoma | II~III | T1N1M0 | |
F09 | M | 62 | Larynx | Squamous cell carcinoma | III | T1N1M0 | |
F10 | M | 64 | Head and neck, oral cavity | Squamous cell carcinoma | III | T2N2M0 | |
F11 | F | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
F12 | M | 64 | Pharynx | Squamous cell carcinoma | III | T2N0M0 | |
G01 | F | 77 | Head and neck, upper lip | Basal cell carcinoma | T2N0M0 | ||
G02 | M | 64 | Head and Neck, left upper mandible | Adenocarcinoma | III | T4N0M0 | |
G03 | F | 57 | Head and neck, salivary gland | Adenoid cystic carcinoma | T3N0M0 | ||
G04 | M | 42 | Head and Neck, left parotid gland | Adenoid cystic carcinoma | T3N0M0 | ||
G05 | F | 35 | Lymph node, neck | Metastatic carcinoma | |||
G06 | M | 54 | Lymph node, neck | Metastatic squamous cell carcinoma | |||
G07 | M | 72 | Head and Neck, left neck | Metastatic squamous cell carcinoma | |||
G08 | M | 27 | Head and neck, salivary gland | Non-Hodgkin T-cell lymphoma? | |||
G09 | M | 68 | Head and neck, right upper mandible | Non-Hodgkin lymphoma (NK cell?) | |||
G10 | M | 18 | Scalp | Melanoma | |||
G11 | F | 77 | Head and neck, nasal cavity | Melanoma | |||
G12 | M | 33 | Scalp | Dermatofibrosarcoma protuberans | |||
H01 | F | 77 | Head and neck, upper lip | Basal cell carcinoma | T2N0M0 | ||
H02 | M | 64 | Head and Neck, left upper mandible | Adenocarcinoma | III | T4N0M0 | |
H03 | F | 57 | Head and neck, salivary gland | Adenoid cystic carcinoma | T3N0M0 | ||
H04 | M | 42 | Head and Neck, left parotid gland | Adenoid cystic carcinoma | T3N0M0 | ||
H05 | F | 35 | Lymph node, neck | Metastatic carcinoma | |||
H06 | M | 54 | Lymph node, neck | Metastatic squamous cell carcinoma | |||
H07 | M | 72 | Head and Neck, left neck | Metastatic squamous cell carcinoma | |||
H08 | M | 27 | Head and neck, salivary gland | Non-Hodgkin T-cell lymphoma? | |||
H09 | M | 68 | Head and neck, right upper mandible | Non-Hodgkin lymphoma (NK cell?) | |||
H10 | M | 18 | Scalp | Melanoma | |||
H11 | F | 77 | Head and neck, nasal cavity | Melanoma | |||
H12 | M | 33 | Scalp | Dermatofibrosarcoma protuberans | |||
null |
bottom of page